Effects of Primary Care Provider Characteristics on Changes in Behavioral Health Delivery During a Collaborative Care Trial.
Elizabeth A McGuier, David J Kolko, K Ashana Ramsook...
https://pubmed.ncbi.nlm.nih.gov/31760174/Actively Recruiting
Led by University of Pittsburgh · Updated on 2026-02-09
450
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are conducting a randomized clinical trial to evaluate ways to improve the use of an evidence-based care model called Doctor Office Collaborative Care DOCC in pediatric primary care settings. This intervention targets the management of childhood behavior problems and comorbid ADHD. The study focuses on testing implementation strategies aimed at either the care team providers or the practice leadership to see how these approaches impact the delivery and uptake of DOCC in diverse pediatric offices. The trial involves up to 24 pediatric primary care practices that will first receive standard DOCC training and materials. Practices are then randomly assigned to one of four groups no additional support beyond training, support for the care team through coaching and consultation TEAM, support for practice leadership through facilitation LEAD, or both TEAM and LEAD support combined. TEAM and LEAD strategies are delivered via regular videoconference meetings over time to enhance the delivery of DOCC treatment sessions focused on behavior and ADHD management for children. Participants include practice staff members and caregivers of children aged 5 to 12 with behavior problems. Data is collected from practice staff at multiple time points up to 24 months and from caregivers up to 12 months to measure the implementation and treatment outcomes. Researchers assess the number of DOCC encounters, care management skills, and changes in symptoms of ADHD, oppositional defiant disorder, conduct disorder, anxiety, and depression, as well as pediatric health quality. The study aims to provide knowledge on how to best support pediatric practices in delivering this collaborative care model.
CONDITIONS
SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care
K
Kevin M Rumbarger, BA
D
David J Kolko, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pittsburgh
Lead Sponsor
American Academy of Pediatrics
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | DOCC with TEAM support | Standard DOCC implementation | DOCC with LEAD support | DOCC with TEAM + LEAD support |
|---|---|---|---|---|
| What it is | DOCC delivered with added team‑level coaching and consultation (TEAM support). | Standard doctor‑office collaborative care (DOCC) implemented without additional implementation supports. | DOCC delivered with leadership‑level facilitation and support (LEAD support). | DOCC delivered with both team‑level coaching and leadership‑level facilitation (TEAM + LEAD support). |
| Role in trial | Experimental arm testing added team‑level support. | Control arm representing basic implementation of DOCC. | Experimental arm testing added leadership‑level support. | Experimental arm testing combined team‑level and leadership‑level support. |
| Primary use | Tests whether team‑level implementation support improves DOCC uptake and delivery. | Implements standard collaborative care model for pediatric behavior problems and ADHD. | Tests whether leadership facilitation enhances DOCC implementation. | Tests whether both team and leadership supports facilitate DOCC implementation more than either alone. |
| How it is given or performed | Includes regular virtual coaching or consultation to care team (~once per month) on collaborative care workflow and roles. | DOCC delivered by practice team without added support strategies. | Includes monthly virtual meetings to facilitate leadership support addressing organizational barriers and capacity for DOCC. | Includes both team‑level coaching and leadership facilitation via monthly virtual meetings. |
| Evidence status | Efficacy under evaluation; evidence base pending trial results. | Collaborative care for pediatric behavior problems has shown benefit in randomized trials of DOCC versus enhanced usual care. | Efficacy under evaluation; evidence base pending trial results. | Efficacy under evaluation; evidence base pending trial results. |
| Important limitations | Effectiveness of team‑level implementation support not yet known until trial completion. | Evidence of collaborative care comes from cluster trials that may differ in practice context or implementation details. | Effectiveness of leadership‑level implementation support not yet known. | Combined implementation support effectiveness not yet established. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual) to determine eligibility
Duration - Up to 12 months of DOCC treatment sessions
Participants receive the Doctor Office Collaborative Care (DOCC) intervention, an evidence-based behavioral treatment for child behavior problems and ADHD. Practices are randomized to receive different implementation support strategies including coaching for care teams (TEAM), facilitation for practice leadership (LEAD), both, or standard implementation with technical support only. Treatment involves sessions with caregivers and children covering behavior management and ADHD topics.
Multiple treatment sessions scheduled by practices with caregivers and children; implementation support includes approximately monthly virtual meetings with care teams and/or practice leaders depending on assigned group
Duration - Up to 24 months of follow-up assessments after treatment begins
Caregivers, providers, and teachers complete assessments at multiple timepoints to evaluate changes in symptoms, care management competencies, and professional perceptions over the course of 24 months.
Assessments occur at baseline, 3, 6, 12, 18, and 24 months depending on participant role; visits may be virtual or in-person
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Elizabeth A McGuier, David J Kolko, K Ashana Ramsook...
https://pubmed.ncbi.nlm.nih.gov/31760174/David J Kolko, John V Campo, Kelly Kelleher...
https://pubmed.ncbi.nlm.nih.gov/20495474/David J Kolko, John Campo, Amy M Kilbourne...
https://pubmed.ncbi.nlm.nih.gov/24664093/Hao Yu, David J Kolko, Eunice Torres
https://pubmed.ncbi.nlm.nih.gov/28333516/David J Kolko, Elizabeth A McGuier, Renee Turchi...
https://pubmed.ncbi.nlm.nih.gov/35193619/David J Kolko, John V Campo, Amy M Kilbourne...
https://pubmed.ncbi.nlm.nih.gov/22064876/David J Kolko, Jonathan A Hart, John Campo...
https://pubmed.ncbi.nlm.nih.gov/32503395/Elizabeth A McGuier, David J Kolko, Mary Lou Klem...
https://pubmed.ncbi.nlm.nih.gov/34174962/University of Pittsburgh
Lead Sponsor
American Academy of Pediatrics
Collaborating Sponsor